Atherogenesis involves an early endothelial dysfunction hallmarked by elevated free radical production and increased adhesiveness for monocytes. It was hypothesized that activation of the tissue renin angiotensin system may contribute to the endothelial alteration. To test this hypothesis, thoracic aortae were isolated from normocholesterolemic (NC; n = 6) and hypercholesterolemic (HC; n = 6; diet: 0.5% cholesterol; 6 weeks) New Zealand white rabbits, and incubated for 2 h with the angiotensin II (Ang II) receptor antagonist Sar-1,Ile-8-Ang II, the antioxidant pyrolidine dithiocarbamate (PDTC) and the protein kinase C (PKC) antagonist staurosporin. Superoxide production from aortic segments was measured by lucigeninenhanced chemiluminescence. In comparison to the normocholesterolemic state, hypercholesterolemia led to a significant increase in superoxide production (221 ± 44%, p Ͻ 0.02); this was reduced by ex vivo treatment of the vessel segment with Ang II-antagonist (to 130 ± 29%; p Ͻ 0.04 vs HC), or PKC-antagonist (to 86 ± 26%; p Ͻ 0.001 vs HC), or PDTC (to 103 ± 27%; p Ͻ 0.02 vs HC). Monocyte-endothelial interaction was assessed by functional binding assay. When compared to normocholesterolemic rabbits, hypercholesterolemia led to a twofold increase in monocyte binding (74 ± 13 vs 37 ± 4 monocytoid cells per high power field (m/hpf); p Ͻ 0.03). The Ang II-antagonist and the PKC-antagonist led to a normalization of monocyteendothelial binding (Ang II-antagonist: 37 ± 9 m/hpf; PKC-antagonist: 41 ± 17 m/hpf; p Ͻ 0.05). In conclusion, these results indicate that hypercholesterolemia activates the tissue renin angiotensin system, which results in an increased endothelial production of superoxide and monocyte adhesiveness. Ang II-antagonist inhibits free radical production and monocyte adhesion through a mechanism which may include PKC.
Introduction
Recent data suggest that the renin angiotensin system (RAS) may play an important role in the pathogenesis of atherosclerosis. In humans, an upregulation of angiotensinconverting enzyme (ACE) was associated with an enhanced risk of myocardial infarction, 1 and ACE inhibitors seem to reduce the incidence of reinfarction. 2,3 Indeed, ACE expression could be observed in lipid-laden macrophages as well as in a human monocytoid cell line after incubation with acetylated low density lipoprotein (LDL). 4 Also, ACE to the initiation or progression of atherosclerosis by stimulating expression of adhesion molecules and subseqent adhesion of monocytes. 8 Furthermore, Ang II has been shown to induce NADH and NADPH oxidase activity with resulting superoxide production. [9] [10] [11] In this study, we set out to assess in cholesterol-fed rabbits whether a cholesterol-induced increase in monocyte adhesion and oxidative stress can be altered by an Ang II-antagonist, or (PKC)antagonist, or the antioxidant pyrolidine dithiocarbamate (PDTC).
Methods

Animals
Twelve male New Zealand white rabbits (NZW) weighing 3.8 ± 1.5 kg were entered into the study after 1 week of acclimation in the housing facilities of the Stanford University Department of Comparative Medicine. All animals were inspected prior to the study by a veterinarian and monitored daily by technicians and investigators. The experimental protocols were approved by the Administrative Panel on Laboratory Animal Care of Stanford University and were performed in accordance with the recommendations of the American Association for the Accreditation of Laboratory Animal Care. Animals were then randomly divided into two groups: six rabbits received normal rabbit chow (NC) while the other six rabbits were fed a high cholesterol diet (HC) until sacrifice (0.5%; Dyets, Bethlehem, PA, USA).
Experimental protocol
Animals were sacrificed 6 weeks after initiation of the hypercholesterolemic diet by exsanguination. Thoracic aortae were isolated from normocholesterolemic (NC) and hypercholesterolemic (HC) NZW, the adventitia removed, and 10-mm segments carefully opened longitudinally. Thoracic aortae from NC rabbits were incubated in PBS only, whereas those from HC rabbits were incubated in random order with one of the following agents: (1) 1 M non-selective Ang II receptor antagonist Sar-1,Ile-8-Ang II (SAR);
(2) 25 M antioxidant PDTC; (3) 2 nM PKC-antagonist staurosporin (ST); and (4) in PBS only. SAR and ST are initially dissolved in DMSO and then diluted 1:100 in PBS. PDTC is dissolved in PBS. After 2 h of incubation functional monocyte binding assay and chemiluminescence for superoxide production were performed.
Biochemistry
Blood samples were collected at the time of sacrifice for measurement of total serum cholesterol. These were immediately centrifuged for 15 min at 4°C and 3000 rpm. The serum was separated and stored at −80°C until analysis. Total serum cholesterol and high density lipoprotein (HDL) cholesterol were enzymatically measured with a spectrophotometric assay (Sigma).
Functional monocyte binding assay
After incubation with either PBS or the investigational drugs, segments were washed with binding buffer, and monocyte binding assay was performed as previously described. 12 In brief, segments of thoracic aortae were fixed to the culture dishes with the endothelial surface exposed to the medium containing isolated, TRITC-labeled (3 g/ml; Molecular Gibco/BRL Probes, Gaithersburg, MD, USA) murine monocytoid cells (WEHI 78/24; ATCC, Manassas, VA, USA). Culture dishes were then placed on a rocking platform (Research Products International Corp., Mount Prospect, IL, USA) for 30 min. After washing, segments were placed on glass slides for counting of adherent cells under epifluorescent microscopy.
Superoxide production
Superoxide anion production by rabbit aortic rings was measured via lucigenin-enhanced chemiluminescence in a liquid scintillation counter (Packard, Downers Grove, IL, USA) programmed for single photon counting. This method has been previously described by other investigators. 13, 14 The final concentration of lucigenin was 0.25 mM dissolved in PBS to a total volume of 5 ml per scintillation vial. Initially, the background chemiluminescence was measured for 15 min. Thereafter, the aortic rings were carefully positioned in the scintillation vials with the lumen directed toward the detector. Upon the addition of the aortic rings into the test vials, phorbol-12-myristate-13-acetate (PMA; a stimulator of respiratory burst) was immediately added in a final concentration of 2 M dissolved in dimethylsulfoxide (DMSO). Chemiluminescence readings of aortic rings were recorded for the duration of 15 min. Readings were Vascular Medicine 2001; 6: 133-138 expressed as total counts minus the average background activity. The rings were then blotted dry, weighed and dissolved in 1 ml of 1 N NaOH for protein analysis. All data were expressed as total counts per mg of protein over a 15min period. Data were expressed as a percentage of the counts of untreated aortic segments of cholesterol-fed rabbits (HC = 100%) for each series of experiments. The percentage calculated experiment was then added and divided by the number of exerperiments performed.
Statistical analyses
For all statistical tests differences were considered statistically significant if the two-sided probability of the observed result under the null hypothesis was Յ0.05. Results are expressed as mean ± SE. All calculations were performed using SPSS  (SPSS, Inc., Chicago, IL, USA). Analysis of variance (ANOVA) was performed to identify a significant difference among the mean values of a variable measured in more than two groups. When analysis of variance was significant, comparisons of the mean values were made by paired Student's t-test with Fisher's exact test correction.
Results
Monocyte binding assay (Figure 1)
Monocyte-endothelial interaction was assessed by functional binding assay. In comparison to the endothelial surface of the aortae from NC rabbits, the endothelial surface of aortae from HC animals was more adhesive, with a twofold higher number of monocytes adhering to the intimal surface in the functional binding assay (74 ± 32 vs 37 ± 10 monocytoid cells per high power field (m/hpf); p Ͻ 0.03). When segments of HC rabbits were incubated with the Ang II receptor antagonist SAR, the number of monocytes adhering to the endothelial surface was significantly reduced (SAR vs vehicle: 37 ± 49 vs 74 ± 32 m/hpf, p Ͻ 0.05). A similar effect was seen when segments from HC animals were incubated with the PKC-antagonist ST (ST vs vehicle: 41 ± 37 vs 74 ± 32 m/hpf; p Ͻ 0.05). Incubation with PDTC tended to reduce the number of adhering monocytes in comparison to vehicle alone; this did not reach statistical difference (PDTC vs vehicle: 56 ± 11 vs 74 ± 32 m/hpf, p = NS).
After incubation with PDTC, ST, or SAR, the number of monocytes adhering to the HC aortae were not different from the number of monocytes adhering to the NC aortae.
Superoxide anion production (Figure 2)
The aortae from HC rabbits manifested a more than twofold increase in superoxide production compared to the aortae from their NC littermates (795 ± 277 vs 227 ± 89 counts/mg of tissue, p Ͻ 0.05). When vessel segments of HC rabbits were incubated ex vivo with the Ang II receptor antagonist Sar-1,Ile-8 (423 ± 162 counts/mg of tissue), or PKC-antagonist ST (197 ± 65 counts/mg of tissue), or PDTC (234 ± 160 counts/mg of tissue), superoxide production was normalized to levels not different from those observed in the aortae from NC animals, and was significantly reduced in comparison to aortae from HC animals (all p Ͻ 0.05 vs HC).
There was a highly significant correlation between mon- ocyte binding and superoxide production (r = 0.650; p Ͻ 0.001).
Discussion
The main findings of this study are:
1) Hypercholesterolemia increases endothelial adhesiveness and superoxide production in the cholesterol-fed rabbit. 2) These abnormalities can be reversed by antagonists of the angiotensin II receptor, protein kinase C, or the antioxidant PDTC. These data are consistent with a cholesterol-induced activation of the tissue renin angiotensin system (RAS), and a contribution of the RAS to oxidative stress and activation of endothelial-monocyte interaction.
Effects of Ang II-antagonist on monocyte binding
Ang II participates at many points in the initiation and progression of atherosclerosis. Ang II induces adhesion molecule expression in human endothelial cells and activates human monocytes, resulting in increased adhesion to human endothelial cells. 8 Ang II also is chemotactic for T lymphocytes 15 and stimulates growth, migration, and matrix production in smooth muscle cells, [16] [17] [18] [19] [20] [21] [22] [23] potentially contributing to lesion formation and plaque growth. Furthermore, treatment with ACE inhibitors reduces lesions of experimental atherosclerosis in Watanabe rabbits, cholesterol-fed rabbits, or cholesterol-fed cynomolgus monkeys. [5] [6] [7] The reduction of Ang II production 24 plus the increase in bradykinin accumulation and nitric oxide production may account for the vasoprotective effects of ACE inhibitors.
In order to explore further the role of the tissue RAS in atherogenesis as well as the antiatherogenic effects of Ang II-antagonists in the hypercholesterolemic state, we performed monocyte binding assays and superoxide measurements in cholesterol-fed rabbits. Aortae from hypercholesterolemic rabbits were significantly more adhesive for monocytes. Ex vivo incubation with an Ang II-antagonist reduced monocyte binding to levels not different from those observed in normocholesterolemic rabbits. This implies that hypercholesterolemia activates the tissue RAS. This observation is consistent with the observation that ACE expression is increased in THP-1 monocytoid cells after differentiation into macrophage-like cells, and is further increased by exposing the cells to acetylated LDL. 4 Together with the observation that in vivo lipid-laden plaque macrophages express ACE, 4 our data suggest that the vascular RAS is activated in hypercholesterolemia.
Effects of Ang II on superoxide production
Ang II has been shown to induce NADH and NADPH oxidase activity with resulting superoxide production in vascular smooth muscle cells. 11 The superoxide radical has numerous effects on cell function, promoting atherogenic processes such as growth of vascular smooth muscle cells, lipid peroxidation, inactivation of nitric oxide and stimulation of adhesion molecule expression. [25] [26] [27] [28] In accordance with these reports from other groups, we observed increased superoxide anion production in hypercholesterolemic rabbits which was normalized to levels not different from normocholesterolemic rabbits after incubation with an Ang II-antagonist. This again supports the hypothesis that the tissue renin angiotensin is activated by hypercholesterolemia and contributes to oxidative stress in the vessel wall.
Ang II decreases NO activity 29 and endothelium-dependent vasorelaxation, which can be restored by Ang II-antagonists. 30, 31 Restoration of NO activity may itself reduce intracellular oxidative stress. 32 NO can scavenge superoxide anion, although the product of this reaction, peroxynitrate anion, is itself a highly reactive free radical. 33 However, it is possible that peroxynitrate anion could subsequently nitrosate sulfhydryl groups to form S-nitrosothiols, which are known to induce vasodilation, inhibit platelet aggregation, and interfere with leukocyte adherence to the vessel wall. 34, 35 Another way by which NO may ameliorate oxidative stress is by terminating the autocatalytic chain of lipid peroxidation that is initiated by oxLDL or intracellular generation of oxygen-derived free radicals. 36 Finally, NO may directly suppress the generation of oxygen-derived free radicals by nitrosylating, and thereby inactivating oxidative enzymes. This hypothesis is supported by the observation that the generation of superoxide anion by stimulated neutrophils is reduced by their exposure to exogenous NO. 37 Although we cannot discount the effects of AT-2, it has previously been shown that the effect of Ang II on superoxide production is mediated via the AT-1 receptor. 38 Our Vascular Medicine 2001; 6: 133-138 data, however, do not allow us to distinguish between the AT-1-vs AT-2-mediated effects due to the non-specific nature of the chosen Ang II-antagonist.
We and others have previously shown that monocyte adhesion to endothelial cells is increased in the hypercholesterolemic state. In vitro and in vivo evidence suggests that NO suppresses the expression of MCP-1, a major chemokine for monocytes. 32, 39 NO appears to exert its effects by reducing intracellular oxidative stress, thereby defusing oxidant-triggered transcription. This may be one mechanism through which NO can serve as an endogenous antiatherogenic molecule. It is well established that hypercholesterolemia reduces the activity of endothelium-derived NO. [40] [41] [42] In parallel, the endothelium begins to generate superoxide anion. 13 This alteration in endothelial redox state triggers a transcriptional cascade that results in the activation of genes encoding molecules that regulate endothelial adhesiveness. 25, 43 As shown in this study, an Ang II-antagonist can ameliorate these deleterious effects.
Effects of PDTC on monocyte binding and superoxide anion production
In the present study, we have demonstrated that incubation with the antioxidant PDTC reduces superoxide production in the hypercholesterolemic state. Several lines of evidence indicate that reactive oxygen intermediates activate NF-B. 44 In fact, radical scavengers such as PDTC decrease NF-B activation and the gene expression of MCP-1 and other inflammatory genes. 45 Recent data show that reactive oxygen intermediates also seem to be involved in the intracellular transduction of Ang II signal. 46 Our data showing PDTC inhibiting the atherogenic effects induced by hypercholesterolemia are in agreement with this mechanism.
Ang II elicits an increase in NF-B activation and MCP-1 expression that was prevented by preincubation of cells with PDTC, an inhibitor of NF-B activation. 47 Furthermore, the stimulated expression of vascular cell adhesion molecule-1, an endothelial adhesion molecule implicated in atherogenesis 48, 49 can be blocked by the antioxidant PDTC, 25 as shown in different cell types. 44 We hypothesized that incubation with PDTC would block the Ang II-induced oxidative stress and thereby reduce monocyte binding. Indeed, PDTC tended to reduce monocyte binding in this model.
PKC plays a critical role in signal transduction pathways leading to a variety of cellular functions, such as cell growth and differentiation. Previous studies have shown that H 2 O 2 is capable of activating PKC in a variety of cell types, including vascular cells. 50, 51 Moreover, vascular cells themselves can produce superoxide via a PKC-sensitive mechanism which involves activation of a membrane-associated NAD(P)H-dependent oxidase. 10 Also, Ang II has been shown to induce the generation of superoxide anion by endothelial cells; a process that can be antagonized by inhibitors of PKC. 9, 10 Ang II has been shown to promote oxidative stress not only through a PKC-dependent pathway but also by activating NAD(P)H-dependent oxidases via AT1-receptor stimulation, which is considered to be the most important vascular source of superoxide. Indeed, Warnholtz et al 38 reported that hypercholesterolemia is associated with AT1receptor upregulation, endothelial dysfunction, and increased NADH-dependent vascular superoxide pro-duction, an effect that could be blocked by an AT1-receptor antagonist (Bay 10-6734). Since also a reduction of early plaque formation was observed, a crucial role of angiotensin II-mediated superoxide production in the early stage of atherosclerosis has beeen postulated. Our findings are consistent with a PKC-mediated pathway mediating the Ang II-induced oxidative stress.
